ADCT

NYSE · Biotechnology

Adc Therapeutics Sa

Penny Stocks Biotech Stocks Healthcare Stocks

$1.13

+0.00 (+0.00%)

As of Aug 8, 10:21 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 8 67%

Hold 3 25%

Sell 1 8%

Price Target

Analyst Price Target +1,631.9% upside

Low Target $11.03

Average Target $19.57

High Target $23.80

Current Price $1.13

Current
$1.13

Target
$19.57

$11.03 $19.57 avg $23.80

Scenario Analysis

Bear Case

$11.03

876.1%

Low target

Base Case

$19.57

+1,631.9%

Avg target

Bull Case

$23.80

+2,006.2%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$4.98

-77.3% from high

52-Week Low

$0.78

+44.9% from low

Target vs 52W High

$19.57

+293.0% vs high

Next Earnings Report

Aug 13, 2026 · Before Market Open

until earnings

EPS Est: $-0.22

Earnings in 3 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.0%